2.Ambroxol for the prevention of respiratory distress syndrome in preterm infants: a meta analysis.
Zhi-Qun ZHANG ; Xian-Mei HUANG ; Hui LU
Chinese Journal of Contemporary Pediatrics 2010;12(11):858-863
OBJECTIVETo evaluate the efficacy and safety of ambroxol in the prevention of respiratory distress syndrome (RDS) in preterm infants.
METHODSElectronic searches were performed in the Cochrane Library, PubMED, EMBASE, Chinese CBM, Chinese VIP Database, Chinese Wanfang Database and Chinese CNKI Database up to the year of 2009 for randomized controlled trials (RCT) on ambroxol for the prevention of RDS in preterm infants. The meeting articles related to the RCT were manually searched in Pediatrics and Pediatric Research. Meta analysis was performed for the results of homogeneous studies by the Cochrane Collaboration's software RevMan 5.0.17.
RESULTSSix RCTs involving 823 preterm infants were included, and the quality assessment for the trials demonstrated 1 article as A class, 1 article as B class and 4 articles as C class. The Meta analysis showed that ambroxol administration significantly reduced the incidence of RDS (OR=0.24, 95%CI: 0.15 - 0.64, P<0.01), bronchopulmonary dysplasis (BPD, OR=0.41, 95%CI: 0.23 - 0.75, P<0.01), intraventricular hemorrhage (IVH, OR=0.39, 95%CI:0.24 - 0.64, P<0.01), patent ductus arteriosus (PDA, OR=0.33, 95%CI: 0.17 - 0.67, P<0.01) and pulmonary infection (OR=0.24, 95%CI:0.14 - 0.38, P<0.01). No adverse events related to the ambroxol treatment were reported.
CONCLUSIONSThe current evidence shows that early use of ambroxol can reduce the risk of RDS, BPD, IVH, PDA and pulmonary infection in preterm infants.
Ambroxol ; therapeutic use ; Bronchopulmonary Dysplasia ; prevention & control ; Cerebral Hemorrhage ; prevention & control ; Ductus Arteriosus, Patent ; prevention & control ; Humans ; Infant, Newborn ; Infant, Premature ; Randomized Controlled Trials as Topic ; Respiratory Distress Syndrome, Newborn ; prevention & control
3.Protective effect of luteolin-7-O-β-D-glucuronide against oxygenglucose deprivation-induced H9C2 cardiomyocytes injury
Hai-Feng ZHANG ; Lu LI ; Sheng-Qun HOU ; Li-Hui LU ; Xian-Chu HAN ; Zhen-Zhen SONG ; Ying SUN ; Fang WANG
Chinese Journal of Pharmacology and Toxicology 2018;32(4):332-333
OBJECTIVE To investigate the protective effect and mechanisms of luteolin-7-O-β-d-glucuronide (LGU) on oxygen glucose deprivation (OGD)-induced H9C2 cardiomyocytes injury. METH-ODS The protective effect of LGU on OGD-induced H9C2 cardiomyocytes death were investigated by MTT assay. The microfilament change of H9C2 cardiomyocytes was detected by phalloidin staining and the lactate dehydrogenase (LDH) leakage rate was also detected by LDH kit. In order to explore the possible mechanisms of LGU, ATP content, intracellular Ca2+fluorescent intensity and concentra-tion, mitochondrial membrane potential (MMP)and the expressions of apoptosis-related proteins were detected by ATP kit,CLSM(Fluo-3/AM probe),Ca2+kit,CLSM(JC-1 probe)and western blotting meth-od, respectively. RESULTS The inhibition of H9C2 cardiomyocyte survival rate inducedby OGD was improvedby pretreated with LGU in a concentrationdependent manner. The microfilaments injury as well as the increase of LDH leakage rate were also improvedby pretreated with LGU.The ATP content was significantly decreased,intracellular Ca2+fluorescent intensity and concentration were significantly increased and the MMP was significantly decreased 4 hafter OGD. LGU significantly reversed the de-crease of intracellular ATP content,the increase of Ca2+fluorescent intensity and concentration and the decrease of MMP.The release of cytochrome C,the expressionsof caspase-9 and caspase-3 in H9C2 cardiomyocytes were increased 16 h after OGD.LGUsignificantly inhibited the changes of these apop-tosis-related proteins. CONCLUSION LGU has a significant protective effect against OGD-induced H9C2 cardiomyocytes injury through inhibiting calcium overload,increasing ATP content,improving mi-tochondrial function and inhibiting apoptosis.
4.The reverse first dorsal metatarsal artery flap for the defects of the distal foot.
Xian-Cheng WANG ; Qun QIAO ; Ke-Ming QI ; Bai-Cheng ZHAO ; Qing LU
Chinese Journal of Plastic Surgery 2005;21(2):101-103
OBJECTIVETo explore a new method to reconstruct the defect of the distal foot.
METHODSA distally based dorsum pedis island flap pedicled with the first dorsal metatarsal artery was designed and transferred to the defect of the distal foot.
RESULTSFive patients were treated with this flap, which ranged from 2 cm x 4 cm to 6 cm x 7 cm in size. Four flaps survived completely, one flap had marginal necrosis and healed after conservative therapy.
CONCLUSIONSThe reverse first dorsal metatarsal artery flap, with good blood circulation and easy manipulation, is a good option for the defects of the distal foot.
Adolescent ; Adult ; Child ; Female ; Foot Injuries ; surgery ; Humans ; Male ; Metatarsus ; blood supply ; Middle Aged ; Skin Transplantation ; methods ; Surgical Flaps ; blood supply ; Young Adult
5.Study on measuring units of Chinese medicine in Song dynasties.
Rui-Xian ZHANG ; Qin LU ; Wei ZHANG ; Mu-Qun ZHANG
China Journal of Chinese Materia Medica 2008;33(19):2277-2279
The original changes of the weight measuring unit of medicine in the Song dynasties was the appearance of Dengzi (small steelyard for weighing money). The "larger scale" and "smaller scale" were unified. The measuring unit "qian" was widely used, and furthermore "Cheng" and "zi" were used as measuring units related to medicine.
China
;
History, Medieval
;
Medicine, Chinese Traditional
;
history
;
methods
6.Neuroprotective effect of luteolin-7-O-β-D-glucuronide in a rat model offocal cerebral ischemia
Sheng-Qun HOU ; Jia-Ying YE ; Hai-Feng ZHANG ; Li-Hui LU ; Xian-Chu HAN ; Ming-Ming LIU ; Ting LI ; Fang WANG
Chinese Journal of Pharmacology and Toxicology 2018;32(4):268-269
OBJECTIVE To investigate the neuroprotective effect and possible mechanisms of lute-olin-7-O-β-D-glucuronide (LGU) against focalcerebral ischemic injury. METHODS The focal cerebral ischemic injury model was established by middle cerebral artery occlusion (MCAO). Male Sprague Dawley rats were randomly divided into sham group,model group(MCAO),LGU group(0.24,0.72 and 2.16 mg·kg-1)and positive control group(Edaravone at 5 mg·kg-1).LGU was injected intravenously 30 min after MCAO.Neurological severity score,infarct volume and brain water content were detected 24 h after MCAO and the levels of Na+-K+ATPase,Ca2+ATPase,TNF-α and IL-1β were detected to explore the possible mechanisms.For the therapeutic time window test,LGU(0.72 mg·kg-1)was injected intrave-nously 0.5, 2, 4, 6, 8, 10 and 12 h respectively after MCAO. To evaluate motion behavior, LGU were injected intravenously 30 min after MCAO and once per day during detection period. The changes of motor coordination were detected by rotating rod method and grip strength analysis, and the changes of gaits were detected using DigiGait Imaging System. RESULTS LGU improved the neurological severity score, infarct volume ratio and brain water content. The therapeutic time window of LGU for cerebral infarction and brain edema was at least 6 h and for neurological dysfunction was 12 h.LGU also prolonged the latency on rotarod, increased the forelimb tension and improved 8 gait parameters, including stance duration,stride length,stance width,paw area,paw area variability,gait symmetry,ataxia coefficient and tau propulsion.Furthermore,LGU increased Na+-K+-ATPase and Ca2+-ATPase levels in the cortex and hippocampus in the ischemic side,reduced the levels of TNF-α and IL-1β in the serum. CONCLUSION LGU has a significant neuroprotective effect against cerebral ischemic injury via improving energy metabolism and reducing inflammation.
7.A clinical study of recombinant human granulocyte colony-stimulating factor on prevention of leukopenia caused by chemotherapy
Ya-Bin SHI ; Jing-Sheng HE ; Xu-Mei SONG ; Yun-Hua WANG ; Xue-Hong ZHU ; Yu-Guo ZHAO ; Lei KOU ; Qun-Xian LU ;
Cancer Research and Clinic 2006;0(11):-
Objective To observe the preventive value of recombinant human granulocyte colony stimulating factor(rhG-CSF)in cancer patients after chemotherapy.Methods In the open study,enrolled 52 patients with previously untreated cancer and with normal bone marrow function were randomly divided into 2 matched groups,A and B group.Each patient received one cycle of chemotherapy.In the study cycle,the pa- tients received a single subcutaneous injection of rhG-CSF 150 ?g before 24 hours of chemotherapy and in control cycle the patients only received chemotherapy.Efficacy and safety parameters were monitored.Results The incidence rates of leukopenia in the 26 valuable study cycles and 26 valuable control cycles were 19.23 % and 53.85 %,There were significant lower than those of group B(P
8.Study on other measuring units of Chinese medicine in Sui and Tang dynasties.
Rui-Xian ZHANG ; Qin LU ; Wei ZHANG ; Mu-Qun ZHANG
China Journal of Chinese Materia Medica 2008;33(18):2136-2139
Besides the changes in weight measuring units, the other units also changed. "Larger and smaller liter" affected traditional Chinese medicine. Length measuring units was little used, and the irregular measuring units such as imitate units, quantity units, and assessing units remained in some extent. Because the regular measuring units gradually replaced the irregular ones, some doctors made investigates to the conversion of these measuring units.
History, Ancient
;
Medicine, Chinese Traditional
;
history
;
methods
9.Study on volume and length units of Chinese medicine in song dynasties.
Rui-Xian ZHANG ; Qin LU ; Wei ZHANG ; Mu-Qun ZHANG
China Journal of Chinese Materia Medica 2008;33(21):2574-2576
In the Song dynasties, the irregular measuring units were seldom used in medicine and length units were no longer used in medicine. The volume units changed from "ancient ones" to "modern ones". There were necessary regulations on the conversion of measuring units of medicine in medical books officially published. Doctor Chenyan made detailed investigations to ancient measuring units.
History, Medieval
;
Medicine, Chinese Traditional
;
history
10.Establishment of a high expressing system of human coagulant factor VIII in vitro.
Hai CHENG ; Kai-Lin XU ; Hai-Ying SUN ; Qun-Xian LU ; Xu-Peng HE ; Xiu-Ying PAN
Chinese Journal of Hematology 2009;30(3):166-170
OBJECTIVETo construct a recombinant lentiviral vector (pXZ208-BDDhFVIII) mediating B-domain-deleted human coagulation factor VIII (BDDhFVIII) gene and investigate its expression in HLF, Chang-Liver and MSC cells.
METHODSBDDhFVIII gene fragment was separated by endonuclease digestion and was cloned into the multiple cloning sites of pXZ208 to construct a recombinant lentiviral vector pXZ208-BDDhFVIII. Viral particles were prepared by means of three-plasmid cotransfection of 293T package cells by calcium phosphate precipitation. After infection, the coagulant activity of human FVIII in the culture medium of 293T, HLF, Chang-Liver and MSC cells was assayed by one-stage method. The gene transduction efficiency was assayed by flow cytometry (FCM). Furthermore, PCR was performed to test the integration of BDDhFVIII.
RESULTSThe infection rates of HLF, Chang-Liver and MSC were (74.52 +/- 7.57)%, (27.24 +/- 6.53)% and (42.34 +/- 5.84)% respectively. The activities of FVIII in supernatants of HLF, Chang-Liver and MSC were (54.1 +/- 5.6)%, (22.5 +/- 2.9)% and (12.5 +/- 2.7)% respectively. BDDhFVIII gene integration was detected in all the infected cells.
CONCLUSIONThe recombinant lentiviral vector pXZ208-BDDhFVIII was successfully constructed and efficiently integrated into target cells to express human FVIII activity in vitro.
Cell Line ; Factor VIII ; biosynthesis ; genetics ; metabolism ; Gene Expression ; Genetic Vectors ; Humans ; Lentivirus ; genetics ; Plasmids ; Transfection